227 related articles for article (PubMed ID: 35378658)
1. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?
Jara LJ; Vera-Lastra O; Mahroum N; Pineda C; Shoenfeld Y
Clin Rheumatol; 2022 May; 41(5):1603-1609. PubMed ID: 35378658
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.
Ameratunga R
Expert Rev Vaccines; 2022 Sep; 21(9):1177-1184. PubMed ID: 35695410
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.
Safary A; Esalatmanesh K; Eftekharsadat AT; Jafari Nakjavani MR; Khabbazi A
Int Immunopharmacol; 2022 Sep; 110():109061. PubMed ID: 35978510
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
Caron P
Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
6. Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants.
Vera-Lastra O; Ordinola Navarro A; Cruz Domiguez MP; Medina G; Sánchez Valadez TI; Jara LJ
Thyroid; 2021 Sep; 31(9):1436-1439. PubMed ID: 33858208
[No Abstract] [Full Text] [Related]
7. Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.
Pujol A; Gómez LA; Gallegos C; Nicolau J; Sanchís P; González-Freire M; López-González ÁA; Dotres K; Masmiquel L
J Endocrinol Invest; 2022 Apr; 45(4):875-882. PubMed ID: 34792795
[TBL] [Abstract][Full Text] [Related]
8. Insights into new-onset autoimmune diseases after COVID-19 vaccination.
Guo M; Liu X; Chen X; Li Q
Autoimmun Rev; 2023 Jul; 22(7):103340. PubMed ID: 37075917
[TBL] [Abstract][Full Text] [Related]
9. New-onset autoimmune phenomena post-COVID-19 vaccination.
Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
11. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.
İremli BG; Şendur SN; Ünlütürk U
J Clin Endocrinol Metab; 2021 Aug; 106(9):2600-2605. PubMed ID: 34043800
[TBL] [Abstract][Full Text] [Related]
12. New-onset Thyroid Eye Disease after COVID-19 Vaccination in a Radioactive Iodine-Treated Graves' Disease Patient: A Case Report and Literature Review.
Im Teoh JH; Mustafa N; Wahab N
J ASEAN Fed Endocr Soc; 2023; 38(1):125-130. PubMed ID: 37252417
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
Kang SH; Kim MY; Cho MY; Baik SK
J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Poh XY; Lee IR; Lim C; Teo J; Rao S; Chia PY; Ong SWX; Lee TH; Lin RJH; Ng LFP; Ren EC; Lin RTP; Wang LF; Renia L; Lye DC; Young BE
Trials; 2022 Jun; 23(1):498. PubMed ID: 35710572
[TBL] [Abstract][Full Text] [Related]
15. Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report.
Lasagna A; Lenti MV; Cassaniti I; Sacchi P
Immunotherapy; 2022 Aug; 14(12):915-925. PubMed ID: 35694999
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune liver diseases and SARS-CoV-2.
Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
[TBL] [Abstract][Full Text] [Related]
17. Silent thyroiditis following vaccination against COVID-19: report of two cases.
Capezzone M; Tosti-Balducci M; Morabito EM; Caldarelli GP; Sagnella A; Cantara S; Alessandri M; Castagna MG
J Endocrinol Invest; 2022 May; 45(5):1079-1083. PubMed ID: 35034341
[TBL] [Abstract][Full Text] [Related]
18. Immunological Facet and Inception after Post-COVID-19 Vaccination.
Ray SK; Mukherjee S
Infect Disord Drug Targets; 2023; 23(5):e060423215496. PubMed ID: 37038664
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
Ruggeri RM; Giovanellla L; Campennì A
J Endocrinol Invest; 2022 Dec; 45(12):2283-2289. PubMed ID: 35829989
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
